Physician profile
Joseph Brading
NPI 1780819920
$1,313.96
in general payments reported to CMS, 2019-2025
19 companies · $73.84 in 2025
The $73.84 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $258 · 2023: $16.53 · 2024: $212 · 2025: $73.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263 · Travel and Lodging: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.83 |
| Travel and Lodging | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $199.99 | 2023-2024 | Ekosonic |
| Glaxosmithkline, LLC. | $143.29 | 2019 | |
| Genzyme Corporation | $131.63 | 2019-2020 | |
| Mylan Specialty L.P. | $123.33 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $94.11 | 2019 | |
| Insmed, INC. | $89.21 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $79.10 | 2019-2020 | |
| Abiomed | $73.84 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.62 | 2019 | |
| Shire North American Group INC | $54.16 | 2019 | |
| Electromed, INC. | $52.55 | 2019 | |
| Sunovion Pharmaceuticals INC. | $50.70 | 2019 | |
| Janssen Pharmaceuticals, INC | $34.14 | 2019-2020 | |
| Philips North America LLC | $32.53 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $29.00 | 2024 | Uptravi, Opsumit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $19.27 | 2020 | |
| Jazz Pharmaceuticals INC. | $19.10 | 2020 | |
| Circassia INC. | $13.30 | 2019 | |
| Veran Medical Technologies, INC. | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Brading listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.